In recent years, the commercialisation of technology has attracted considerable attention. The technology development process, from invention to commercialisation, contains numerous uncertainties and factors that influence the duration of patent commercialisation, such as appropriability, lead time, science linkage, and number of patent citations. However, most studies have neglected the relationship between organisational capabilities and the duration of commercialisation. This study used dynamic capabilities to construct a research framework for the factors that influence the commercialisation of biotechnological patents based on the primary theoretic basis of organisational capabilities. Following a literature review, this study proposed hypotheses regarding the influence that four major capabilities of an organization's dynamic capabilities have on the commercialisation of biotechnological patents. Data were collected using questionnaires distributed to companies in the biotechnology industry. Regarding the 119 questionnaires distributed, 28 of the collected questionnaires were valid. The validity and reliability of these questionnaires were analysed using SPSS 17.0. Subsequently, a survival analysis was conducted to verify the hypotheses proposed in this study. The results were used to verify whether the various dynamic capabilities, such as sensing, learning, and integration, as well as whether the possession of complementary assets, significantly influenced the feasibility of commercialising a specific patent. In addition, we examined whether company locations (within science parks or not) significantly influenced the feasibility of commercialising a specific patent.